132 related articles for article (PubMed ID: 31320870)
1. HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer.
Kitahara M; Hozumi Y; Nakamura A; Tachi K; Saitoh H; Iijima T
Case Rep Oncol; 2019; 12(2):473-479. PubMed ID: 31320870
[TBL] [Abstract][Full Text] [Related]
2. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
3.
Ulaner GA; Castillo R; Wills J; Gönen M; Goldman DA
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1420-1427. PubMed ID: 28456837
[TBL] [Abstract][Full Text] [Related]
4. [Conversion Therapy for HER2-Positive Metastatic Breast Cancer with Intrathoracic Lymph Node Metastasis].
Kono H; Maeda H; Yao S; Takahashi M; Yokoi S; Goi T; Imamura Y
Gan To Kagaku Ryoho; 2020 Jun; 47(6):977-980. PubMed ID: 32541178
[TBL] [Abstract][Full Text] [Related]
5. Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report.
Miyake M; Yamada A; Miyake K; Endo I
Surg Case Rep; 2019 Feb; 5(1):22. PubMed ID: 30771195
[TBL] [Abstract][Full Text] [Related]
6. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
7. Appendicitis caused by the metastasis of HER2-positive breast cancer.
Mori R; Futamura M; Morimitsu K; Yoshida K
Surg Case Rep; 2016 Dec; 2(1):104. PubMed ID: 27683008
[TBL] [Abstract][Full Text] [Related]
8. Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
Park JC; Ma TM; Rooper L; Hembrough T; Foss RD; Schmitt NC; Sawhney R; Flanders A; Kang H
Head Neck; 2018 Dec; 40(12):E100-E106. PubMed ID: 30478962
[TBL] [Abstract][Full Text] [Related]
9. Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.
Fujii K; Watanabe R; Ando T; Kousaka J; Mouri Y; Yoshida M; Imai T; Nakano S; Fukutomi T
Biomed Rep; 2017 Dec; 7(6):535-542. PubMed ID: 29188058
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Stage IV Metaplastic Breast Cancer in Which Primary Tumor Was Removed after Treatment with Anti-HER2 Systemic Therapy].
Egawa C; Inatome J; Sakamoto T; Naito A; Murakami K; Katsura Y; Ohmura Y; Kagawa Y; Takeno A; Takeda Y; Murata K; Takatsuka Y; Goto T; Nagano T
Gan To Kagaku Ryoho; 2018 Jan; 45(1):154-156. PubMed ID: 29362339
[TBL] [Abstract][Full Text] [Related]
11. Metastatic gastric carcinoma from breast cancer mimicking primary linitis plastica: A case report.
Yagi Y; Sasaki S; Yoshikawa A; Tsukioka Y; Fukushima W; Fujimura T; Hirosawa H; Izumi R; Saito K
Oncol Lett; 2015 Dec; 10(6):3483-3487. PubMed ID: 26788154
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
Chen X; Yuan Y; Gu Z; Shen K
Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
[TBL] [Abstract][Full Text] [Related]
13. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
Inoue Y; Yamashita N; Tokunaga E; Tanaka K; Ueo H; Saeki H; Oki E; Yamamoto H; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1917-1921. PubMed ID: 28373460
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.
Aurilio G; Disalvatore D; Pruneri G; Bagnardi V; Viale G; Curigliano G; Adamoli L; Munzone E; Sciandivasci A; De Vita F; Goldhirsch A; Nolè F
Eur J Cancer; 2014 Jan; 50(2):277-89. PubMed ID: 24269135
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Sobic Saranovic D; Stojiljkovic M; Susnjar S; Odalovic S; Artiko V; Pavlovic S; Grozdic-Milojevic I; Obradovic V
Neoplasma; 2016; 63(2):313-21. PubMed ID: 26774154
[TBL] [Abstract][Full Text] [Related]
16. [A Vesected Case of Pancreatic Metastasis from Breast Cancer Which Recurred Six Years after Breast Surgery].
Nakama Y; Maruyama Y; Hisaka T; Yasumoto M; Okabe Y; Naito Y; Yamaguchi M; Tanaka M; Tanaka H; Akagi Y; Okuda K
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2309-2311. PubMed ID: 32156914
[TBL] [Abstract][Full Text] [Related]
17. A rare case of isolated adrenal metastasis of invasive ductal breast carcinoma.
Andjelić-Dekić N; Božović-Spasojević I; Milošević S; Matijašević M; Karadžić K
Srp Arh Celok Lek; 2014; 142(9-10):597-601. PubMed ID: 25518541
[TBL] [Abstract][Full Text] [Related]
18. 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
Ulaner GA; Hyman DM; Lyashchenko SK; Lewis JS; Carrasquillo JA
Clin Nucl Med; 2017 Dec; 42(12):912-917. PubMed ID: 28872549
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.
Erdem GU; Altundag K; Ozdemir NY; Sahin S; Demirci NS; Karatas F; Bozkaya Y; Aytekin A; Tasdemir V; Aslan AC; Sever AR; Zengin N
J BUON; 2017; 22(2):365-376. PubMed ID: 28534357
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
